Stopping HIV where it starts - IAVI. IAVI is a nonprofit scientific research organization dedicated to addressing urgent, unmet global health challenges includi
People at risk of getting HIV will now have an injectable option for pre-exposure prophylaxis (Prep) after the US regulator approved its use in adults and adole
Scientists using vaginal fluids to develop vaccine
HEALTH & SCIENCE
Scientists at UoN are using women due to their high predisposition to sexual infections compared to men. [Courtesy]
Scientists at the University of Nairobi are studying the vaginal secretions of volunteers to develop vaccines that stop the HIV virus during intercourse for women only.
The scientists attached to the Kenya Aids Vaccine Initiative (KAVI) are using women due to their high predisposition to sexual infections compared to men. Their genitalia have a wider surface of interaction with the virus doubling likelihood of infection at 6.6 per cent compared to 3.1 per cent for men.